-
Sector Analysis
NewEMEA Gambling and Betting Sponsorship Landscape – Analysing Biggest Deals, Latest Trends, Top Sponsor Brands and Sponsorship Sector
EMEA Gambling and Betting Sponsorship Landscape Overview In 2024, gambling and betting brands with headquarters in the EMEA region acquired 658 deals, with a combined estimated yearly value of $977.58 million. Across the region, soccer has the greatest volume of gambling & betting agreements. The EMEA gambling and betting sponsorship landscape report provides deep insights into the EMEA gambling and betting sector sponsorship market trend, most active sport, and product categories. The report has also analyzed the key product sponsorship...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MGD-014 in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MGD-014 in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MGD-014 in Human Immunodeficiency Virus (HIV) Infections...
-
Product Insights
NewAlpha Tau Medical Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Alpha Tau Medical Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Alpha Tau Medical Ltd (Alpha Tau) is medical technology company that focuses on the discovery, development and marketing of Alpha DaRT (diffusing alpha-emitters radiation therapy) seed for the treatment of solid cancers. The company is evaluating Alpha DaRT therapy for the treatment of skin cancer, oral cavity cancer, head-and-neck cancer and breast cancer in clinical studies. It is...
-
Sector Analysis
India Cold Chain Market Summary, Competitive Analysis and Forecast to 2028
Cold Chain in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cold chain is a temperature-controlled supply chain, used to preserve and maintain the quality and integrity of perishable goods, that are sensitive to environmental conditions. Cold chains help to reduce the spoilage...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VB-1953 in Acne Vulgaris
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VB-1953 in Acne Vulgaris report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VB-1953 in Acne Vulgaris Drug Details: VB-1953 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MGD-024 in Systemic Mastocytosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MGD-024 in Systemic Mastocytosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MGD-024 in Systemic Mastocytosis Drug Details: MGD-024 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MGD-024 in Hairy Cell Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MGD-024 in Hairy Cell Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MGD-024 in Hairy Cell Leukemia Drug Details: MGD-024 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tebotelimab in Hematological Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tebotelimab in Hematological Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tebotelimab in Hematological Tumor Drug Details: Tebotelimab (MGD-013) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tebotelimab in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tebotelimab in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tebotelimab in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: Tebotelimab (MGD-013)...